Taken from: The Guardian online, 27/01/2016, Laura Entis

This article explores mobile technology and how it is adapted to the medical industry through the clinical trial process. In 2007, the FDA established the Clinical Trials Transformation Initiative (CTTI) in partnership with Duke University, in part to kickstart mobile clinical trials. Article notes that Dr Martin Landry, professor of medicine and epidemiology at Oxford University and one of the leaders of CTTI’s mobile clinical trial project, estimates that in some cases, shifting to a mobile-based trial may reduce costs by 10-fold. This cost cutting, coupled with the fact that mobile trials’ recruitment efforts are not limited by geography, has the potential to advance our scientific understanding of rare diseases.

Read the full article in The Guardian.